tradingkey.logo

Helius Medical Technologies Inc

HSDT
5.500USD
+0.170+3.19%
Cierre 11/07, 16:00ETCotizaciones retrasadas 15 min
74.86KCap. mercado
PérdidaP/E TTM

Helius Medical Technologies Inc

5.500
+0.170+3.19%

Más Datos de Helius Medical Technologies Inc Compañía

Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.

Información de Helius Medical Technologies Inc

Símbolo de cotizaciónHSDT
Nombre de la empresaHelius Medical Technologies Inc
Fecha de salida a bolsaJun 27, 2014
Director ejecutivoMr. Dane C. Andreeff
Número de empleados21
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 27
Dirección642 Newtown Yardley Road
CiudadNEWTOWN
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal18940
Teléfono12159446100
Sitio Webhttps://heliusmedical.com/
Símbolo de cotizaciónHSDT
Fecha de salida a bolsaJun 27, 2014
Director ejecutivoMr. Dane C. Andreeff

Ejecutivos de Helius Medical Technologies Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Chief Financial Officer, Treasurer, Secretary, Director
Chief Financial Officer, Treasurer, Secretary, Director
15.00
-6.25%
Mr. Blane Walter
Mr. Blane Walter
Independent Director
Independent Director
2.00
-33.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
2.00
--
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Sherrie Perkins
Ms. Sherrie Perkins
Independent Director
Independent Director
--
--
Vice Adm. (Retd.) Edward M. (Ed) Straw
Vice Adm. (Retd.) Edward M. (Ed) Straw
Independent Director
Independent Director
--
--
Mr. Dane C. Andreeff
Mr. Dane C. Andreeff
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Cosmo Jiang
Mr. Cosmo Jiang
Director
Director
--
--
Dr. Joseph Chee
Dr. Joseph Chee
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Chief Financial Officer, Treasurer, Secretary, Director
Chief Financial Officer, Treasurer, Secretary, Director
15.00
-6.25%
Mr. Blane Walter
Mr. Blane Walter
Independent Director
Independent Director
2.00
-33.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Director
Independent Director
2.00
--
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Dr. Antonella Favit-Van Pelt, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Sherrie Perkins
Ms. Sherrie Perkins
Independent Director
Independent Director
--
--
Vice Adm. (Retd.) Edward M. (Ed) Straw
Vice Adm. (Retd.) Edward M. (Ed) Straw
Independent Director
Independent Director
--
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
Canada
26.00K
60.47%
Other revenue
10.00K
23.26%
United States
7.00K
16.28%
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: vie., 7 de nov
Actualizado: vie., 7 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Fusion Summer Ltd
16.95%
Pantera Capital Partners LP
9.67%
Solana Rocket Holdings Ltd
9.65%
Polar Asset Management Partners Inc.
5.41%
Wayne (Morehead Daniel)
0.02%
Otro
58.30%
Accionistas
Accionistas
Proporción
Fusion Summer Ltd
16.95%
Pantera Capital Partners LP
9.67%
Solana Rocket Holdings Ltd
9.65%
Polar Asset Management Partners Inc.
5.41%
Wayne (Morehead Daniel)
0.02%
Otro
58.30%
Tipos de accionistas
Accionistas
Proporción
Corporation
26.60%
Investment Advisor
9.69%
Hedge Fund
5.41%
Individual Investor
0.02%
Otro
58.27%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
24
3.90M
10.09%
+3.90M
2025Q2
37
12.45K
1.83%
+11.99K
2025Q1
40
16.72K
1.11%
-2.03K
2024Q4
43
261.97K
7.03%
-14.04K
2024Q3
43
183.78K
9.58%
-95.02K
2024Q2
46
285.33K
12.75%
+168.92K
2024Q1
47
120.01K
13.52%
+4.71K
2023Q4
50
81.05K
12.51%
-44.86K
2023Q3
52
56.40K
16.69%
-20.37K
2023Q2
56
42.39K
14.78%
-10.21K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fusion Summer Ltd
6.83M
17.56%
+6.83M
--
Sep 18, 2025
Pantera Capital Partners LP
3.89M
9.99%
+3.89M
--
Sep 18, 2025
Wayne (Morehead Daniel)
10.00K
0.03%
+10.00K
--
Sep 18, 2025
Wealthspire Advisors LLC
6.00K
0.02%
+6.00K
--
Jun 30, 2025
Desjardins Securities Inc.
4.00K
0.01%
+4.00K
--
Jun 30, 2025
Leonite Fund I LP
3.26K
0.01%
+3.26K
--
Jun 05, 2025
UBS Financial Services, Inc.
737.00
0%
+737.00
--
Jun 30, 2025
Ver más

ETFs relacionados

Nombre
Proporción
Sin datos

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Dec 31, 2020
Merger
35→1
Dec 31, 2020
Merger
35→1
Fecha
Tipo
Relación
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Aug 16, 2023
Merger
50→1
Dec 31, 2020
Merger
35→1
Dec 31, 2020
Merger
35→1
Dec 31, 2020
Merger
35→1
Dec 31, 2020
Merger
35→1
KeyAI